AARP, Other Groups Express Concern About Reference-Based Pricing

AARP on Tuesday is expected to issue a warning to seniors and send a letter to CMS to express concern about reference-based pricing, under which some Medicare drug plans charge beneficiaries additional payments for choosing brand-name drugs if generic versions are available, the

More: continued here

Filed under: Medicare / Medicaid / Tricare on December 19th, 2008